|
1
|
Brinton LA, Smith L, Gierach GL, Pfeiffer
RM, Nyante SJ, Sherman ME, Park Y, Hollenbeck AR and Dallal CM:
Breast cancer risk in older women: Results from the NIH-AARP diet
and health study. Cancer Causes Control. 25:843–857. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
National Cancer Institute: Breast cancer.
What You Need To Know About. National Institutes of Health;
Bethesda, MD: 2012
|
|
3
|
Nyante SJ, Dallal CM, Gierach GL, Park Y,
Hollenbeck AR and Brinton LA: Risk factors for specific
histopathological types of postmenopausal breast cancer in the
NIH-AARP diet and health study. Am J Epidemiol. 178:359–371. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sasco AJ: Breast cancer and the
environment. Horm Res. 60(Suppl 3): S502003. View Article : Google Scholar
|
|
5
|
Ruddy KJ, Greaney ML, Sprunck-Harrild K,
Meyer ME, Emmons KM and Partridge AH: Young women with breast
cancer: A focus group study of unmet needs. J Adolesc Young Adult
Oncol. 2:153–160. 2013. View Article : Google Scholar :
|
|
6
|
John EM, Hopper JL, Beck JC, Knight JA,
Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd
N, et al: The breast cancer family registry: An infrastructure for
cooperative multinational, interdisciplinary and translational
studies of the genetic epidemiology of breast cancer. Breast Cancer
Res. 6:R375–R389. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fantozzi A and Christofori G: Mouse models
of breast cancer metastasis. Breast Cancer Res. 8:2122006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zetter BR: Angiogenesis and tumor
metastasis. Annu Rev Med. 49:407–424. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mera H, Kawashima H, Yoshizawa T,
Ishibashi O, Ali MM, Hayami T, Kitahara H, Yamagiwa H, Kondo N,
Ogose A, et al: Chondromodulin-1 directly suppresses growth of
human cancer cells. BMC Cancer. 9:1662009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing S, Wang Z, Xi H, Zhou L, Wang D, Sang
L, Wang X, Qi M and Zhai L: Establishment of rat bone mesenchymal
stem cell lines stably expressing Chondromodulin I. Int J Clin Exp
Med. 5:34–43. 2012.PubMed/NCBI
|
|
11
|
Lin L, Fu X, Zhang X, Chen LX, Zhang JY,
Yu CL, Ma KT and Zhou CY: Rat adipose-derived stromal cells
expressing BMP4 induce ectopic bone formation in vitro and in vivo.
Acta Pharmacol Sin. 27:1608–1615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S, Zeng X, Liu Y, Liang C, Zhang H,
Liu C, Du W and Zhang Z: Construction and characterization of a
PDCD5 recombinant lentivirus vector and its expression in tumor
cells. Oncol Rep. 28:91–98. 2012.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Zheng K, Li HY, Su XL, Wang XY, Tian T, Li
F and Ren GS: Chemokine receptor CXCR7 regulates the invasion,
angiogenesis and tumor growth of human hepatocellular carcinoma
cells. J Exp Clin Cancer Res. 29:312010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar
|
|
16
|
Wels J, Kaplan RN, Rafii S and Lyden D:
Migratory neighbors and distant invaders: Tumor-associated niche
cells. Genes Dev. 22:559–574. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
19
|
Ferrara N: Vascular endothelial growth
factor as a target for anticancer therapy. Oncologist. 9(Suppl 1):
S2–S10. 2004. View Article : Google Scholar
|
|
20
|
Ferrara N: VEGF as a therapeutic target in
cancer. Oncology. 69(Suppl 3): S11–S16. 2005. View Article : Google Scholar
|
|
21
|
Shibuya M: VEGF-VEGFR signals in health
and disease. Biomol Ther (Seoul). 22:1–9. 2014. View Article : Google Scholar
|
|
22
|
Ma J and Waxman DJ: Combination of
antiangiogenesis with chemotherapy for more effective cancer
treatment. Mol Cancer Ther. 7:3670–3684. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miura S, Kondo J, Kawakami T, Shukunami C,
Aimoto S, Tanaka H and Hiraki Y: Synthetic disulfide-bridged cyclic
peptides mimic the anti-angiogenic actions of chondromodulin-I.
Cancer Sci. 103:1311–1318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hakuno D and Fukuda K: Role of
anti-angiogenic factor chondromodulin-I for maintaining cardiac
valvular function. Clin Calcium. 17:361–372. 2007.In Japanese.
PubMed/NCBI
|
|
25
|
Klinger P, Surmann-Schmitt C, Brem M,
Swoboda B, Distler JH, Carl HD, von der Mark K, Hennig FF and Gelse
K: Chondromodulin 1 stabilizes the chondrocyte phenotype and
inhibits endochondral ossification of porcine cartilage repair
tissue. Arthritis Rheum. 63:2721–2731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hiraki Y, Inoue H, Iyama K, Kamizono A,
Ochiai M, Shukunami C, Iijima S, Suzuki F and Kondo J:
Identification of chondromodulin I as a novel endothelial cell
growth inhibitor. Purification and its localization in the
avascular zone of epiphyseal cartilage. J Biol Chem.
272:32419–32426. 1997. View Article : Google Scholar
|
|
27
|
Fox SB, Generali DG and Harris AL: Breast
tumour angiogenesis. Breast Cancer Res. 9:2162007. View Article : Google Scholar
|
|
28
|
Miller KD: Recent translational research:
Antiangiogenic therapy for breast cancer - where do we stand?
Breast Cancer Res. 6:128–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muruve DA: The innate immune response to
adenovirus vectors. Human Gene Ther. 15:1157–1166. 2004. View Article : Google Scholar
|
